Donor‐specific transfusion via the portal venous route induces prolongation of H‐2‐compatible but not H‐2‐incompatible cardiac graft survival

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Transplant International

• Publication date

  1989-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.1989.tb01866.xPMID 2627262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of pretransplant and posttransplant immunosuppression on cardiac graft survival in the donor-specific transfusion model in mice. Comparison of the effects of cyclophosphamide, procarbazine, cyclosporine, and cortisone.

  1989cited by this paper
• Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats.

  1988cited by this paper
• The role of drug timing and histoincompatibility barrier in prolongation of cardiac graft survival in mice treated with donor-specific blood and cyclophosphamide.

  1988cited by this paper
• Induction of transplantation tolerance by intraportal injection of allogeneic bone marrow cells

  1988cited by this paper
• Tolerance Induction of Alloreactivity by Portal Venous Inoculation with Allogeneic Cells Followed by the Injection of Cyclophosphamide

  1988cited by this paper
• Immunoregulation by antigen/antibody complexes. I. Specific immunosuppression induced in vivo with immune complexes formed in antibody excess.

  1987cited by this paper
• Specific unresponsiveness in rats with prolonged allograft survival is dependent upon the graft and suppressor T cells.

  1987cited by this paper
• Surgical-stress-related suppression of natural killer cell activity: a possible role in tumor metastasis.

  1987cited by this paper
• Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: what is "hepatic tolerance"?

  1987cited by this paper
• TOLERANCE INDUCTION OF ALLOREACTIVITY BY PORTAL VENOUS INOCULATION WITH ALLOGENEIC CELLS FOLLOWED BY THE INJECTION OF CYCLOPHOSPHAMIDE: I. SPECIFIC SUPPRESSION OF ALLOREACTIVE CYTOTOXIC AND DELAYED‐TYPE HYPERSENSITIVITY RESPONSES AS WELL AS ALLOGRAFT REJECTION

  1987cited by this paper
• INDUCTION OF ANTIIDIOTYPIC ANTIBODIES BY BLOOD TRANSFUSIONS: CHARACTERIZATION OF T CELL ALLOANTIGEN‐SPECIFIC RECEPTORS BY SERA FROM TRANSFUSED MICE

  1986cited by this paper
• THE REQUIREMENT FOR THE RENAL TRANSPLANT TO INDUCE ALLOGRAFT UNRESPONSIVENESS BY THE COMBINATION OF EXTRACTED HISTOCOMPATIBILITY ANTIGEN AND CYCLOSPORINE

  1986cited by this paper
• Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.

  1985cited by this paper
• The beneficial transfusion effect on kidney graft survival attributed to clonal deletion.

  1984cited by this paper
• Induction of antibodies by blood transfusions capable of inhibiting responses in MLC.

  1983cited by this paper
• Mouse skin allograft model for study of pregraft blood transfusion.

  1982cited by this paper
• INDUCTION OF SUPPRESSOR CELLS BY DONOR‐SPECIFIC BLOOD TRANSFUSIONS AND HEART TRANSPLANTATION IN RATS

  1981cited by this paper
• Induction of suppressor cells and allograft tolerance.

  1980cited by this paper
• Two distinct antigen-specific suppressor factors induced by the oral administration of antigen

  1980cited by this paper
• Immunologic suppression after oral administration of antigen. II. Antigen-specific helper and suppressor factors produced by spleen cells of rats fed sheep erythrocytes.

  1980cited by this paper
• Correlation Between Anergy and a Circulating Immunosuppressive Factor Following Major Surgical Trauma

  1979cited by this paper
• Inhibition of specific immune responses by feeding protein antigens.

  1979cited by this paper
• Inhibition of specific immune responses by feeding protein antigens. III. Evidence against maintenance of tolerance to ovalbumin by orally induced antibodies.

  1979cited by this paper
• Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration.

  1978cited by this paper
• Immunologic Suppression After Oral Administration of Antigen

  1978cited by this paper
• Immunodepression after major surgery in normal patients.

  1975cited by this paper
• A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes

  1975cited by this paper
• Antibodies to human albumin in cirrhotic sera.

  1974cited by this paper
• Studies on hepatic uptake of antigen. I. Comparison of inferior vena cava and portal vein routes of immunization.

  1973cited by this paper
• Effect of blood transfusions on subsequent kidney transplants.

  1973cited by this paper
• Cell-mediated immunity and blocking antibodies to renal allografts.

  1972cited by this paper
• THE MECHANISM OF SPECIFIC IMMUNOSUPPRESSION OF RENAL ALLOGRAFT REJECTION BY DONOR STRAIN BLOOD

  1972cited by this paper
• Bacterial and dietary antibodies in liver disease.

  1972cited by this paper
• Hepatic Suppression of Sensitization to Antigen absorbed into the Portal System

  1967cited by this paper
• TRANSPLANTATION OF CARDIAC TISSUE INTO THE MOUSE EAR.

  1963cited by this paper
• Immunological Unresponsiveness Produced in Adult Guinea Pigs by Parenteral Introduction of Minute Quantities of Hapten or Protein Antigen.∗

  1962cited by this paper

• EVIDENCE THAT LIPOSOME INCORPORATION OF CYCLOSPORINE REDUCES ITS TOXICITY AND POTENTIATES ITS ABILITY TO PROLONG SURVIVAL OF CARDIAC ALLOGRAFTS IN MICE

  1991cites this paper